Investigation of Small Mobile Stem Cells (SMS Cells) in Participants With Chronic Obstructive Pulmonary Disease (COPD).

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Obstructive Lung Disease
Interventions
BIOLOGICAL

Stem cells

The suspension of stem cells will be put in a medical nebulizer machine, commonly used to deliver medicines into the lungs through inhalation. This means that the participants will breathe in the mist containing the SMS cells, produced by the nebulizer machine. This is a Phase I First-in-Human study, which indicates that this treatment is being studied for the first time in humans.

Trial Locations (1)

3153

RECRUITING

Veritas Research, Bayswater

Sponsors

Lead Sponsor

All Listed Sponsors
lead

SMSbiotech

INDUSTRY

NCT06986070 - Investigation of Small Mobile Stem Cells (SMS Cells) in Participants With Chronic Obstructive Pulmonary Disease (COPD). | Biotech Hunter | Biotech Hunter